Average Co-Inventor Count = 5.96
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Universitá Degli Studi Di Siena (7 from 18 patents)
2. Università Degli Studi Di Roma "la Sapienza" (2 from 56 patents)
3. Azienda Ospedaliera Universitaria Senese (2 from 3 patents)
4. Other (1 from 832,843 patents)
5. Sigma-tau Industrie Farmaceutiche Riunite S.p.a. (1 from 343 patents)
6. Cygnet Biosciences B.v. (1 from 1 patent)
7. Universta' Degli Studi Di Siena (1 from 1 patent)
13 patents:
1. 11814366 - Antiviral compounds and use thereof
2. 11000512 - Use of DDX3 inhibitors as antiproliferative agents
3. 10941121 - Human helicase DDX3 inhibitors as therapeutic agents
4. 10093642 - Multitarget hedgehog pathway inhibitors and uses thereof
5. 10071975 - Macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitors
6. 8895600 - Non peptidic 14-3-3 inhibitors and the use thereof
7. 8685953 - Linear and cyclic guanidine derivatives, method of preparation and uses thereof
8. 8466164 - 4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof
9. 8304410 - Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto
10. 8012970 - Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine, synthesis process and uses thereof
11. 7910581 - Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl] methyl}-4-methylpiperazine, synthesis process and uses thereof
12. 7589086 - Substituted pyrazolo[3,4-D]pyrimidines as anti-tumor agents
13. 7368605 - Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity